- Own the lifecycle planning and successful product launch for a diagnostic portfolio in Hematologic Malignancies, including Lymphoma, Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL), collaborating with cross-functional teams to develop and execute a strategic plan that drives usage, awareness, and advocacy across key stakeholders worldwide.
- Lead a MM/CLL Lifecycle Team that is a cross-functional team accountable for progress on tumor goals and deploying resources to maximize outcomes.
- Drive market access efforts, leading the development of reimbursement dossiers for Medicare/MolDx and commercial payers to secure coverage for non-covered indications.
Requirements
- Bachelor’s degree with 5+ years of relevant experience; advanced degree preferred (MBA or PhD)
experience in product marketing, market analytics at a pharmaceutical / biotech company
- Working knowledge of oncology molecular testing / biomarkers
- Ability to partner and collaborate across a broad range of internal and external partners
- Proven ability to communicate the complex simply (biomarkers, multiple indications, etc.)
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.
Experience
- Hematologic oncology experience strongly preferred - 5+ years
Benefits
Signatera is covered by Medicare for colorectal cancer, muscle invasive bladder cancer, high-risk breast cancer, ovarian cancer, lung cancer, and immunotherapy response monitoring for any solid tumor.
The pay range is listed and actual compensation packages are based on a wide array of factors unique to each candidate, including but not limited to skill set, years & depth of experience, certifications and specific office location.
This range reflects a good-faith estimate of the base pay we reasonably expect to offer at the time of hire. Final compensation will vary based on experience, qualifications, and internal equity considerations.
This position is also eligible for additional compensation and
benefits through Natera’s robust Total Rewards program, including: •
Annual performance incentive bonus •
Long-term equity awards •
Comprehensive health benefits (medical, dental, vision) •
Generous paid time off and company holidays •
Compensation Range $149,600 — $187,000 USD OUR OPPORTUNITY
Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents.
Additionally, Natera employees and their immediate families receive free testing in addition to fertility care benefits. Other
benefits include pregnancy and baby bonding leave, 401k benefits, commuter
Please be advised that Natera will reach out to candidates with a @ natera.com email domain ONLY.
Additional details
Natera a Global Leader in cell-free DNA testing focused on changing the management of disease in reproductive health, oncology, and organ transplantation.
Signatera is a personalized, tumor-informed test for molecular residual disease (MRD) assessment and surveillance monitoring in patients previously diagnosed with cancer.
As an Associate Director of Oncology Lifecycle Management for Hematologic Malignancies you will work in a highly matrixed environment to help shape the strategic direction and drive execution for company success in Hematologic Oncology. Primary Responsibilities:
- Establish tumor-specific goals to be owned by the lifecycle team and across functions.
- Serve as a critical member of clinical/medical teams, helping define and prioritize key indications while identifying and addressing evidence gaps.
- Serve as a critical member on commercial subteams, helping to maximize Natera potential by escalating and addressing critical barriers that limit commercial adoption.
- Maintain a deep expertise in the Hematology Oncology space by integrating real-time customer insights, publications, data presentations, competitive and market intelligence.
- Develop and execute KOL engagement strategies, collaborating with marketing and medical teams to gather insights, build relationships, and foster advocacy.
- Shape the value proposition for Natera’s oncology products in collaboration with Medical Affairs and Commercial Marketing, leveraging clinical evidence and market dynamics.
- Co-lead advisory boards and market research efforts in partnership with Medical Affairs.